• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term durability of molecular and chimerism responses in patients treated with imatinib for chronic myeloid leukemia relapse after allogeneic transplantation.

作者信息

Martín-Palanco Vanesa, Martínez Francisco, Arqueros Victor, Torres Antonio, Román-Gómez José

出版信息

Eur J Haematol. 2011 Aug;87(2):182-5. doi: 10.1111/j.1600-0609.2011.01628.x.

DOI:10.1111/j.1600-0609.2011.01628.x
PMID:21762210
Abstract
摘要

相似文献

1
Long-term durability of molecular and chimerism responses in patients treated with imatinib for chronic myeloid leukemia relapse after allogeneic transplantation.伊马替尼治疗异基因移植后慢性髓性白血病复发患者的分子和嵌合反应的长期耐久性
Eur J Haematol. 2011 Aug;87(2):182-5. doi: 10.1111/j.1600-0609.2011.01628.x.
2
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.对接受甲磺酸伊马替尼（格列卫）治疗的异基因移植后慢性髓性白血病复发患者进行长期随访：持久的细胞遗传学缓解以及转化为完全供体嵌合状态且无移植物抗宿主病。
Clin Cancer Res. 2004 Aug 1;10(15):5065-71. doi: 10.1158/1078-0432.CCR-03-0580.
3
A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.供体淋巴细胞输注或甲磺酸伊马替尼用于异基因干细胞移植后复发的慢性粒细胞白血病患者的比较。
Haematologica. 2006 May;91(5):663-6. Epub 2006 Apr 19.
4
Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia.
Haematologica. 2006 Aug;91(8):1145-6. Epub 2006 Jul 25.
5
Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation.
Leukemia. 2005 Jul;19(7):1262-5. doi: 10.1038/sj.leu.2403752.
6
Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis.
Bone Marrow Transplant. 2007 Feb;39(3):189-91. doi: 10.1038/sj.bmt.1705554. Epub 2007 Jan 8.
7
Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study.慢性粒细胞白血病异基因干细胞移植失败后接受甲磺酸伊马替尼治疗的患者实现持续完全分子缓解：一项前瞻性II期开放标签多中心研究的结果
J Clin Oncol. 2005 Oct 20;23(30):7583-93. doi: 10.1200/JCO.2005.01.3110.
8
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias.
Bone Marrow Transplant. 2004 Nov;34(9):827-8. doi: 10.1038/sj.bmt.1704687.
9
Chronic myeloid leukemia--advances in biology and new approaches to treatment.慢性髓性白血病——生物学进展与新的治疗方法
N Engl J Med. 2003 Oct 9;349(15):1451-64. doi: 10.1056/NEJMra020777.
10
Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.在慢性粒细胞白血病患者接受非处理的异基因骨髓移植后，髓系混合嵌合现象与bcr-abl阳性患者的复发相关。
Haematologica. 2000 Feb;85(2):173-80.